Independent
Tenure on this board
4.0 yrs
Meeting calendar
VREX · Annual meeting · Thursday, February 12, 2026
Varex Imaging Corp
1 nominee · 3 ballot items.
Election of seven directors to the Board; an advisory vote to approve executive compensation (Say-on-Pay) for named executive officers; and ratification of Deloitte & Touche LLP as the independent registered public accounting firm for fiscal year 2026.
Market cap
$444M
1Y TSR
+32.6%
Board grade
C+
Record date
Dec 15, 2025
Filing
DEF 14A
Meeting concluded · Feb 12, 2026
Follow how the vote landed and what changed on Varex Imaging Corp’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
Proposals
On the ballot3
- 1
Election of seven directors to serve until the 2027 Annual Meeting of Stockholders
ManagementBoard: FORElection of seven director nominees to the Board for a one-year term.
- 2
Advisory vote to approve our executive compensation
ManagementBoard: FORAdvisory (non-binding) vote on the compensation of the Named Executive Officers as described in this Proxy Statement.
- 3
Ratification of Deloitte & Touche LLP as our independent registered public accounting firm for fiscal year 2026
ManagementBoard: FORRatification of Deloitte as the independent registered public accounting firm for fiscal year 2026.
Director elections
Nominees on the ballot1
Ownership
Latest 13F quarterTop institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | PZENA INVESTMENT MANAGEMENT LLC | 9.5% | 3,992,280 | $42M |
| 2 | Allspring Global Investments Holdings, LLC | 6.3% | 2,645,969 | $28M |
| 3 | Neuberger Berman Group LLC | 4.6% | 1,924,949 | $20M |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 4.3% | 1,820,336 | $19M |
| 5 | LSV ASSET MANAGEMENT | 4.2% | 1,762,096 | $19M |
| 6 | BlackRock, Inc. | 4.1% | 1,706,796 | $18M |
| 7 | DIMENSIONAL FUND ADVISORS LP | 3.6% | 1,497,855 | $16M |
| 8 | BlackRock, Inc. | 3.5% | 1,467,235 | $16M |
| 9 | COOKE BIELER LP | 3.1% | 1,303,012 | $14M |
| 10 | RICE HALL JAMES ASSOCIATES, LLC | 3.0% | 1,274,818 | $14M |
Peers
Nearest market capOther Healthcare sector meetings6
Upcoming shareholder meetings at Varex Imaging Corp’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Indaptus Therapeutics IncINDP
Annual meeting·Aug 10, 2026·$287M
Aura Biosciences IncAURA
Special meeting·Aug 5, 2026·$712M
Seer IncSEER
Annual meeting·Jul 28, 2026·$119M
Avanos Medical IncAVNS
Special meeting·Jul 22, 2026·$1.2B
Anaptysbio IncANAB
Annual meeting·Aug 11, 2026·$1.6B
Trulieve Cannabis CorpTRLV
Special meeting·Aug 5, 2026·$1.6B
Reference
Frequently asked questions
- When is the Varex Imaging Corp 2026 annual meeting?
- Varex Imaging Corp (VREX) holds its 2026 annual shareholder meeting on Thursday, February 12, 2026.
- What is the record date for the Varex Imaging Corp 2026 meeting?
- The record date for the Varex Imaging Corp 2026 meeting is Monday, December 15, 2025. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Varex Imaging Corp's 2026 meeting?
- The board is presenting 1 director nominee at the Varex Imaging Corp 2026 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Varex Imaging Corp 2026 meeting?
- Shareholders will vote on 3 proposals at the Varex Imaging Corp 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.